Managing Director, Founder, President
CurrentBioBridge® has focused on the innovation chain in biosciences for more than 20 years' successful consultancy. Scope includes ndustrial biotechnology (green chemistry, biomass use for natural products, bioenergy and bioremediation), healthcare, biotechnology, medical devices, biomaterials, agricultural resources, animal health and food. Examples of work include monitoring publicly-funded projects in industrial biotechnology; analysing start-up feasibility in marine metagenomics; business prospects and regulatory strategies for new molecules from transgenic plants; Knowledge Transfer Manager 2006-2009 in the UK's Bioscience for Business KTN, focusing on blue biotech; due diligence for investors in high throughput screen company, novel cell-based treatments for Alzheimer's disease & bone dystrophies, a Scottish biomaterials company, a nutragenomic lifestyle services company, a Northern Ireland animal health company, and other targets for acquisition and flotation; technology and market analyses of university inventions including biotechnology research reagents, a novel microfluidics development, novel ocular lenses, innovations in biomanufacturing measurements, medical applications of terahertz technologies; market dynamics for new cell-based therapies and new pharmaceuticals for asthma and burns; regulatory issues in Europe for GMOs in food, feed, farming and diagnostics; IP and development advice for a 19-project European Biomaterials Network; organises, chairs and presents at conferences on marine biotechnology, natural products for health and wellbeing, bioprocessing, bioremediation and the environment, IP in renewables usw.Mr Meredith Lloyd-Evans, Managing Director of BioBridge Ltd, trained and worked as a vet, then joined SmithKline Animal Health, becoming Technical Director UK and Co-ordinator for vet pharma product development Europe. He managed an IP portfolio at the British Technology Group in biotechnology and biomaterials as well as animal health.